Genetic polymorphisms in carcinogen metabolism predict substrate-induced cytogenetic damage in humans.
Wiencke
J K
JK
Dept. of Epidemiology & Biostatistics, University of California, School of Medicine, San Francisco 94143.
Kelsey
K T
KT
Lamela
R A
RA
Toscano
W A
WA
D000328:Adult; D002273:Carcinogens / Q000378:metabolism* / Q000494:pharmacology; D002478:Cells, Cultured; D005260:Female; D005982:Glutathione Transferase / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008658:Inactivation, Metabolic; D007527:Isoenzymes / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism; D008214:Lymphocytes / Q000187:drug effects / Q000201:enzymology; D008297:Male; D009153:Mutagens / Q000378:metabolism / Q000494:pharmacology; D011110:Polymorphism, Genetic; D012854:Sister Chromatid Exchange / Q000187:drug effects*; D012907:Smoking; D013267:Stilbenes / Q000378:metabolism* / Q000494:pharmacology
D002273:Carcinogens; D007527:Isoenzymes; D009153:Mutagens; D013267:Stilbenes; D005982:Glutathione Transferase; C025906:stilbene oxide